Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Fungal Infection Reports

22-03-2024 | Review

Fungal Infections and Social Determinants of Health: Using Data to Identify Disparities

Authors: Samantha L. Williams, Kaitlin Benedict, Mitsuru Toda

Published in: Current Fungal Infection Reports

Login to get access

Abstract

Purpose of Review

Fungal diseases disproportionately affect certain demographic populations, but few studies have thoroughly investigated the drivers of those disparities. We summarize data sources that can be considered to explore potential associations between fungal diseases and social determinants of health in the United States.

Recent Findings

Sociodemographic disparities are apparent in fungal diseases, and social determinants of health (e.g., income, living conditions, and healthcare access) may be associated with increased risk of infection, severe disease, and poor health outcomes.

Summary

Numerous data sources are available in the United States to analyze the potential association between fungal diseases and underlying social determinants of health. Each source has benefits and limitations that should be considered in the development of analysis plans. Inherent challenges to all fungal disease data (e.g., underdiagnosis, underreporting, and inability to detect people who do not seek medical care) should be noted and accounted for in interpretation of results.
Literature
1.
2.
3.
Rayens E, Rayens MK, Norris KA. Demographic and socioeconomic factors associated with fungal infection risk, United States, 2019. Emerg Infect Dis. 2022;28(10):1955–69.CrossRefPubMedPubMedCentral
4.
Jenks JD, Prattes J, Wurster S, Sprute R, Seidel D, Oliverio M, et al. Social determinants of health as drivers of fungal disease. eClinicalMedicine. 2023;66:102325.CrossRefPubMedPubMedCentral
5.
6.
Weeks WB, Chang JE, Pagán JA, Lumpkin J, Michael D, Salcido S, et al. Rural-urban disparities in health outcomes, clinical care, health behaviors, and social determinants of health and an action-oriented, dynamic tool for visualizing them. PLOS Global Public Health. 2023;3(10):e0002420.CrossRefPubMedPubMedCentral
7.
Tsay SV, Mu Y, Williams S, Epson E, Nadle J, Bamberg WM, et al. Burden of Candidemia in the United States, 2017. Clin Infect Dis. 2020;71(9):e449–53.PubMed
8.
Green BJ. Occupational Fungal Exposure in the United States. In: Viegas C, Viegas S, Gomes A, Täubel M, Sabino R, editors. Exposure to microbiological agents in indoor and occupational environments [Internet]. Cham: Springer International Publishing; 2017 [cited 2024 Jan 12]. p. 3–33. Available from: https://​doi.​org/​10.​1007/​978-3-319-61688-9_​1.
9.
Seth D, Cheldize K, Brown D, Freeman EE. Global Burden of Skin Disease: Inequities and Innovations. Curr Derm Rep. 2017;6(3):204–10.CrossRefPubMed
10.
11.
Goldman AL, McCormick D, Haas JS, Sommers BD. Effects of the ACA’s Health Insurance Marketplaces on the previously uninsured: a quasi-experimental analysis. Health Affairs. 2018;37(4):591–9.CrossRefPubMed
12.
Moser JW, Applegate KE. Imaging and insurance: do the uninsured get less imaging in emergency departments? J Am Coll Radiol. 2012;9(1):50–7.CrossRefPubMed
13.
Richardson A, Allen JA, Xiao H, Vallone D. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477–93.CrossRefPubMed
14.
Selove R, Kilbourne B, Fadden MK, Sanderson M, Foster M, Offodile R, et al. Time from screening mammography to biopsy and from biopsy to breast cancer treatment among Black and White, women medicare beneficiaries not participating in a health maintenance organization. Women’s Health Issues. 2016;26(6):642–7.CrossRefPubMedPubMedCentral
15.
Lukachko A, Olfson M. Race and the clinical diagnosis of depression in new primary care patients. Gen Hosp Psychiatry. 2012;34(1):98–100.CrossRefPubMed
16.
Howell EA, Brown H, Brumley J, Bryant AS, Caughey AB, Cornell AM, et al. Reduction of peripartum racial and ethnic disparities: a conceptual framework and maternal safety consensus bundle. Obstet Gynecol. 2018;131(5):770.CrossRefPubMed
17.
18.
Magaña López M, Bevans M, Wehrlen L, Yang L, Wallen GR. Discrepancies in race and ethnicity documentation: a potential barrier in identifying racial and ethnic disparities. J Racial and Ethnic Health Disparities. 2017;4(5):812–8.CrossRef
19.
Dembosky JW, Haviland AM, Haas A, Hambarsoomian K, Weech-Maldonado R, Wilson-Frederick SM, et al. Indirect estimation of race/ethnicity for survey respondents who do not report race/ethnicity. Med Care. 2019;57(5):e28-33.CrossRefPubMed
20.
21.
Johnson JA, Moore B, Hwang EK, Hickner A, Yeo H. The accuracy of race & ethnicity data in US based healthcare databases: a systematic review. Am J Surg. 2023;226(4):463–70.CrossRefPubMed
22.
Benedict K, Gold JAW, Jenkins EN, Roland J, Barter D, Czaja CA, et al. Low sensitivity of international classification of diseases, tenth revision coding for culture-confirmed candidemia cases in an Active Surveillance System: United States, 2019–2020. Open Forum Infect Dis. 2022;9(9):ofac461.CrossRefPubMedPubMedCentral
23.
24.
Jones JM, Koski L, Khan M, Brady S, Sunenshine R, Komatsu KK. Coccidioidomycosis: an underreported cause of death—Arizona, 2008–2013. Med Mycol. 2018;56(2):172–9.CrossRefPubMed
25.
26.
27.
28.
29.
30.
31.
Metadata
Title
Fungal Infections and Social Determinants of Health: Using Data to Identify Disparities
Authors
Samantha L. Williams
Kaitlin Benedict
Mitsuru Toda
Publication date
22-03-2024
Publisher
Springer US
Published in
Current Fungal Infection Reports
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-024-00494-4
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits